Regeneron
Edit

Regeneron

https://www.regeneron.com/
Last activity: 24.04.2024
Categories: MedTechPageProductScienceSocialContentHealthTechInformationLearnMedia
Please visit www.Regeneron.com/social-media-terms for more information on how to engage with Regeneron on social media. Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. We do not interview candidates on Google Hangouts. Any questions about job listings can be directed to candidatesupport@regeneron.com. Regeneron is a leading science and technology company delivering life-transforming medicines for serious diseases. Founded by physician-scientists nearly 30 years ago, our science-driven approach has resulted in six FDA-approved medicines and numerous product candidates in a range of diseases, including ophthalmology, asthma, atopic dermatitis, pain, cancer and infectious diseases. In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human genetics sequencing efforts in the world and rapid response technologies being used for global good. Milestones 1988: Regeneron is founded by Leonard S. Schleifer, MD, PhD, young neurologist and assistant professor at Cornell University Medical College. Learn more about our history and milestones here: https://www.regeneron.com/history Commenting Guidelines Thank you for visiting our page. This is a place where we hope you will engage with and learn more about our company and take part in open dialogue that respects other members. We want to hear from you and we’ll respond to your comments and questions as soon as possible. We respect your right to voice your opinions, but we reserve the right to remove any comments that are considered inappropriate, off-topic, or abusive. Please don’t use this page to solicit for third-party sites or products. Comments that are factually inaccurate or misleading, violate another's copyright or intellectual property, use profanity or are defamatory will be deleted. The content you read here may contain information related to health, medical and fitness conditions and treatment. It is for informational purposes only and not a substitute for professional medical advice, diagnosis, or treatment. Please always consult your doctor. All comments, visuals, videos and other type of material posted by fans on this site ("User Content") do not necessarily reflect the opinions or ideals of Regeneron, its employees or affiliates. Regeneron assumes no responsibility for the User Content on the page, nor for any error, defamation, libel, slander, omission falsehood, obscenity, pornography, profanity, danger or inaccuracy contained in any User Content. You understand and agree that User Content will be treated as non-confidential and non-proprietary and you are giving us and our affiliates, a royalty-free, irrevocable, perpetual, non-exclusive and fully sublicensable license to use, reproduce, modify, adapt, publish, translate, create derivative works from, distribute, perform and display such User Content in whole or in part, on a worldwide basis, and to incorporate them in other works, in any form, media, technology, or products now known or later developed, including for promotional or marketing purposes; and you further represent, warrant, and covenant that you have and will continue to have the legal right to grant these rights. Please read Facebook's Statements of Rights and Responsibilities for more information. Adverse Events This page is not the best place to discuss safety issues or side effects associated with our products or other company’s products. If you, or someone you know, may have possibly experienced a side effect while taking a Regeneron product please contact our Medical Information Department at 1-855-REGEN-4-U (1-855-734-3648) for further information. You can also report any adverse event directly to your healthcare provider or to the U.S. Food and Drug Administration (FDA) by calling 1-800-FDA-1088 or visiting http://www.fda.gov/Safety/MedWatch.
Likes
14.8K
Followers
305.37K
Website visits
153K /mo.
Mentions
150
Location: United States, New York, Tarrytown
Employees: 10001+
Phone: +1 914-847-7000
Founded date: 1988

Investors 2

Mentions in press and media 150

DateTitleDescriptionSource
24.04.2024Govt expands committee for drugs, medical devices pricing re...-business-s...
22.04.2024Regeneron to Highlight Advances in Genetic Medicine Research...Oral presentations include updated results from clinical study of otoferlin gene therapy DB-OTO demo...einpresswi...
15.04.2024Women of Influence: Health Care 2024 – Ileana Hernandez-labusiness...
15.04.2024Regeneron Ventures Launches with $500 Million Commitment to ...-globenewsw...
07.04.2024Linvoseltamab Pivotal Data Presented at AACR Reinforce High ...Regulatory applications for linvoseltamab currently under review by the U.S. Food and Drug Administr...einpresswi...
25.03.2024Defining Leadership in Clinical Trials: Perspectives from Re...Xtalks Life Science Webinars To learn what qualities are necessary to navigate the evolving landscap...prweb.com/...
15.03.2024A 17-year-old took home $250,000 for his award-winning disco...Science A 17-year-old took home $250,000 for his award-winning discovery in computer 'brains' that c...businessin...
13.03.2024High School Seniors Win $1.8 Million at Regeneron Science Ta...$250,000 top award goes to Achyuta Rajaram in the nation’s oldest and most prestigious Science, Tech...einpresswi...
12.03.2024High School Seniors Win $1.8 Million at Regeneron Science Ta...-globenewsw...
11.03.2024CytomX Therapeutics Reports 2023 Financial Results and Provi...- CX-904 (EGFRxCD3 T-cell engager) initial Phase 1a dose escalation data in solid tumors anticipated...einpresswi...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In